معرفی
Dr. Arnaud Augert is an Assistant Professor in the Department of Pathology at Yale School of Medicine, with a primary affiliation in the Genomics program. He leads the Augert Lab, focusing on dissecting transcriptional and epigenetic mechanisms in cancer, particularly small cell lung cancer (SCLC). His research integrates cell biology, genetics, and molecular biology to identify novel therapeutic strategies.
Education: Dr. Augert holds a PhD in Molecular & Cellular Biology from the Pasteur Institute/Université de Sciences et Techniques de Lille (USTL), an MPhil in Cellular Biology & Physiology from USTL, and a BS in Cellular Biology from the University of Valencia.
Research Interests: Dr. Augert’s work centers on understanding tumor suppressor networks, SCLC pathogenesis, and therapeutic targets such as MAX, NOTCH, and epigenetic regulators. His lab explores mechanisms of transcriptional addiction, metabolic rewiring, and cellular senescence in cancer progression.
Publications: His research has been featured in top journals like Cancer Cell, Cancer Discovery, and Science Signaling, highlighting breakthroughs in SCLC biology and therapeutic approaches. Recent work includes studies on MAX inactivation, NOTCH inhibition, and epigenetic drivers of cancer.
- Scientific Awards:
- ATIP-AVENIR program
- UALC/LCRF grant
- Yale Cancer Center K12 Calabresi Immuno-Oncology Training Program
Advising & Mentorship: Dr. Augert has mentored numerous trainees, including undergraduates, graduate students, and postdoctoral fellows. Current lab members include Yale BBS graduate students (Danny Gallant, Mileena Nguyen) and postdoctoral researchers (Bomiao Hu, Aoqun Song).
Lab Activities: The Augert Lab is part of Yale Cancer Center and collaborates with interdisciplinary teams in Computational Biology, Molecular Medicine, and Pharmacology. They aim to bridge basic science discoveries with translational oncology.
